Searched for
ASTRAZENECA PHARMA INDIA Q2 RESULTS
- India's Spark qualifies for Trackmania event at Esports World CupKunal Upreti, also known as Spark, is the only Indian player to qualify for the Esports World Cup in Trackmania. He secured his spot throug...
ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- HDFC Bank shares in focus as RBI approves 3-month extension for Keki Mistry as interim chairmanHDFC Bank's interim chairman, Keki Mistry, has received a three-month extension from the RBI until September 18, 2026, easing concerns abou...
- AP Intermediate Supplementary Results 2026 out at resultsbie. ap. gov. in, BIEAP 1st, 2nd year results at bie. ap. gov. inresultsbie. ap. gov. in AP Inter Supply Results 2026 Released: The Board of Intermediate Education, Andhra Pradesh has released the AP Inte...
- The 30% smallcap tilt: How Abakkus Flexi Cap Fund is positioning for the next rallyAbakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...
- Dividend alert! Last date to buy Tata Tech, HDB Financial, 6 other stocks for dividends worth Rs 36The shares of Tata Technologies on Thursday will turn ex-record date for a special dividend of Rs 3.35 per share and a final dividend of Rs...
- India adds 4.6 GWh of energy storage capacity in first quarter of 2026: ReportIndia saw a massive surge in battery energy storage capacity in early 2026. The country added 4.6 gigawatt-hours in the first three months,...
- India Inc's sales growth gathers pace in March quarter, led by autos and metals: RBI dataManufacturing companies saw sales jump 14.5 percent in the fourth quarter of 2025-26. Automobiles, electrical machinery, and non-ferrous me...
- Automobiles, electrical machinery push sales of listed private manufacturing companies in Q4: RBI dataIndian manufacturing companies saw sales jump 14.5 percent in early 2026. Automobiles, electrical machinery, and metals led this growth. Ov...
- HCL Tech shares jump 3% after buying stake in Sarvam AI for Rs 1,427 croreHCL Tech share price gained 3% after i invested $150 million in Sarvam AI, India's largest AI startup, acquiring a 10.46% stake. This strat...
- Bonus bonanza! Last date to buy Brigade Enterprises shares for 1:3 bonus issue rewardBrigade Enterprises in May announced its first bonus issue in around seven years, along with the release of its Q4 results. It said its boa...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- India a major growth market for Celonis, says senior execThe Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
Load More
